Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling

Blood

Volumn 113, Issue 13, 2009, Pages 3059-3069

  Beà, Sílvia ^a   Salaverria, Itziar ^a   Armengol, Lluís ^b   Pinyol, Magda ^a   Fernández, Verónica ^a   Hartmann, Elena M ^c   Jares, Pedro ^a   Amador, Virginia ^a   Hernández, Luís ^a   Navarro, Alba ^a   Ott, German ^c,d   Rosenwald, Andreas ^c   Estivill, Xavier ^b   Campo, Elias ^a,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d ROBERT BOSCH HOSPITAL   (Germany)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2C; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BCL2L11 GENE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 18Q; CONTROLLED STUDY; DNA FINGERPRINTING; DNA FLANKING REGION; FAF1 GENE; GENE; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC RECOMBINATION; GENOME; GENOMIC INSTABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; MOBKL2B GENE; PRAME GENE; PRIMARY TUMOR; PRIORITY JOURNAL; RB1 GENE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SP100 GENE; TUMOR SUPPRESSOR GENE; UNIPARENTAL DISOMY; ZNF280B GENE;

EID: 64249136718     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-170183     Document Type: Article

References (60)

1. Lovec H, Grzeschiczek A, Kowalski M-B, Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphomas in transgenic mice. EMBO J. 1994;13:3487-3495.
2. Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene. 2006;25:998-1007.
3. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007;7:750-762.
4. Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G. Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood. 2004;104:904-905.
5. Salaverria I, Zettl A, Bea S, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol. 2007;25:1216-1222.
6. BeaS, RibasM, Hernandez JM, et al. Increased number of chromosomal imbalances and high-level DNAamplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93:4365-4374.
7. Kohlhammer H, Schwaenen C, Wessendorf S, et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood. 2004;104:795-801.
8. Rubio-Moscardo F, Climent J, Siebert R, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood. 2005;105:4445-4454.
9. Allen JE, Hough RE, Goepel JR, et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol. 2002;116:291-298.
10. Bentz M, Plesch A, Bullinger L, et al. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2000;27:285-294.
11. Salaverria I, Espinet B, Carrio A, et al. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques. Genes Chromosomes Cancer. 2008;47:1086-1097.
12. Schraders M, Pfundt R, Straatman HM, et al. Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood. 2005;105:1686-1693.
13. Tagawa H, Karnan S, Suzuki R, et al. Genome-wide array-based CGH for mantle cell lymphoma:identification of homozygous deletions of the pro-apoptotic gene BIM. Oncogene. 2005;24:1348-1358.
14. FlordalTE, IchimuraK, Collins VP, et al. Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma. Leuk Res. 2007;31:1219-1230.
15. Rinaldi A, Kwee I, Taborelli M, et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol. 2006;132:303-316.
16. Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A. Pathogenesis of mantle-cell lym-phoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol. 2005;23:6364-6369.
17. Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol. 2008;142:149-165.
18. Mestre-Escorihuela C, Rubio-Moscardo F,Richter JA, et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lympho-mas. Blood. 2007;109:271-280.
19. Bea S, Campo E. Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior. Haemato-logica. 2008;93:641-645.
20. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454.
21. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949-951.
22. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528.
23. Sharp AJ, Locke DP, McGrath SD, et al. Segmen-tal duplications and copy-number variation in the human genome. Am J Hum Genet. 2005;77:78-88.
24. Stankiewicz P, Shaw CJ, Dapper JD, et al. nome architecture catalyzes nonrecurrent chromosomal rearrangements. Am J Hum Genet. 2003;72:1101-1116.
25. de StahlTD, Sandgren J, Piotrowski A, et al. Profiling of copy number variations(CNVs) in healthy individuals from three ethnic groups using a human genome 32 K BAC-clone-based array. Hum Mutat. 2008;29:398-408.
26. Goidts V, Cooper DN, Armengol L, et al. Complex patterns of copy number variation at sites of seg-mental duplications: an important category of structural variation in the human genome. Hum Genet. 2006;120:270-284.
27. Bailey JA, Eichler EE. Primate segmental duplications: crucibles of evolution, diversity and ease. Nat Rev Genet. 2006;7:552-564.
28. Bea S, Colomo L, Lopez-Guillermo A, et al. Clini-copathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol. 2004;22:3498-3506.
29. Pinyol M, Bea S, Pla L, et al. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood. 2007;109:5422-5429.
30. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 2005;106:3183-3190.
31. Good P. Permutation Tests. New York, NY: Springer-Verlag; 2000.
32. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental dis-omy due to somatic recombination in acute my-eloid leukemias. Cancer Res. 2005;65:375-378.
33. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood. 2008;111:776-784.
34. Walker BA, Leone PE, Jenner MW, et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms,
35. and genes important in the pathogenesis of multiple myeloma. Blood. 2006;108:1733-1743.
36. Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood. 2007;109:1202-1210.
37. Fitzgibbon J, Iqbal S, Davies A, et al. Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia. 2007;21:1514-1520.
38. Durig J, Bug S, Klein-Hitpass L, et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leuke-miawith inv(14)(q11q32). Leukemia. 2007;21: 2153-2163.
39. Nielaender I, Martin-Subero JI, Wagner F, Martinez-Climent JA, Siebert R. Partial uniparen-tal disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lym- phoma. Leukemia. 2006;20:904-905.
40. Serrano E, Carnicer MJ, Orantes V, et al. Unipa- rental disomy may be associated with microsatel- lite instability in acute myeloid leukemia(AML) with a normal karyotype. Leuk Lymphoma. 2008; 49:1178-1183.
41. Raghavan M, Smith LL, Lillington DM, et al. Seg- mental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. Blood. 2008;112:814-821.
42. Yamamoto G, Nannya Y, Kato M, et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide- polymorphism genotyping microarrays. Am J Hum Genet. 2007;81:114-126.
43. Suzuki M, Kato M, Yuyan C, et al. Whole-genome profiling of chromosomal aberrations in hepato- blastoma using high-density single-nucleotide polymorphism genotyping microarrays. Cancer Sci. 2008;99:564-570.
44. Saddler C, Ouillette P, Kujawski L, et al. Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia. Blood. 2008;111:1584-1593.
45. Park MY, Moon JH, Lee KS, et al. FAF1 suppresses IkappaB kinase(IKK) activation by disrupting the IKK complex assembly. J Biol Chem. 2007;282:27572-27577.
46. Liu SY, Chen YT, Tseng MY, et al. Involvement of microtubule-associated protein 2(MAP2) in oral cancer cell motility: a novel biological function of MAP2 in non-neuronal cells. Biochem Biophys Res Commun. 2008;366:520-525.
47. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 2007;8:1006-1016.
48. Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell. 2008;13:188-192.
49. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004;64:3087- 3095.
50. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839-843.
51. TagawaH, Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 2005;19:2013-2016.
52. Zhu Y, Hollmen J, Raty R, et al. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br J Haematol. 2002;119:905-915.
53. Wang Q, Gao F, May WS, et al. Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway. Mol Cell. 2008;29:488-498.
54. Perez-Galan P, Roue G, Villamor N, Campo E, Colomer D. The BH3-mimetic GX15-070 syner- gizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak. Blood. 2007;109:4441-4449.
55. Wiestner A, Tehrani M, Chiorazzi M, et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood. 2007;109:4599-4606.
56. Gruszka-Westwood AM, Atkinson S, Summersgill BM, et al. Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene. Genes Chromosomes Cancer. 2002;33: 206-212.
57. Stallings RL, Nair P, Maris JM, et al. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res. 2006;66:3673-3680.
58. Lucito R, Suresh S, Walter K, et al. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther. 2007;6:1592-1599.
59. Darai-Ramqvist E, Sandlund A, Muller S, et al. Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions. Genome Res. 2008;18:370-379.
60. Camps J, Grade M, Nguyen QT, et al. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. cer Res. 2008;68:1284-1295.